title: [Advances in surgical therapy for hepatocellular carcinoma].
abstract: The first therapeutic option for hepatocellular carcinoma (HCC) is systematic liver resection. Recent advances in operation techniques and peri-operative management have contributed to enlarging the indications of liver resection for HCC, and served to improve the long-term survival. Only liver resection can be a curative treatment for HCC with portal venous tumor thrombus.
authors.affiliation: Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Hasegawa
authors.forename: Norihiro
authors.initials: N
authors.lastname: Kokudo
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Makuuchi
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000601:surgery*; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery*; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome